The mechanism of T-VECs includes the lysis of tumor cells after entry and the release of granulocyte–macrophage colony stimulating factor (GM-CSF) and tumor-derived antigens, enhancing the T cell response on the tumor [54]. Here, CSF2 is linked to neoplasm.